R&D investment Hanmi Pharmaceutical 2017-2023
In 2023, Hanmi Pharmaceutical Co., Ltd. and its subsidiaries' R&D investment amounted to a total of around 205 billion South Korean won. This represents an increase from the previous year.
Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2023 (in billion South Korean won)*
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Pharmaceutical industry in Scandinavia
Pharmaceutical sales
8
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Value of pharmaceutical sales in Norway 2008-2022
- Basic Statistic Value of pharmaceutical sales in Sweden 2000-2022
- Basic Statistic Sales of pharmaceuticals in Norway 2020-2021, by prescription type
- Basic Statistic Revenue of pharmaceuticals in Sweden by type 2023
- Basic Statistic Revenue of most dispensed drugs at pharmacies in Denmark 2022
- Basic Statistic Sales volume pharmaceuticals in Norway by drug category 2022
- Basic Statistic Largest pharmaceutical classes in Sweden 2023, by sales value
Patents and clinical trials
6
- Basic Statistic Number of applications for clinical trials in Denmark 2013-2021, by sponsor
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021, by type of actor
- Basic Statistic Number of applications for clinical trials in Sweden 2014-2021, by sponsor
- Basic Statistic Number of biotechnology patents in Denmark 2011-2021
- Basic Statistic Number of biotechnology patents in Norway 2011-2021
- Basic Statistic Number of biotechnology patents in Sweden 2011-2021
Trade
5
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2023
- Basic Statistic Import and export value of basic pharmaceutical products in Norway 2009-2023
- Basic Statistic Net export value of pharmaceuticals from Sweden 2012-2022
- Basic Statistic Import value of pharmaceuticals into Sweden 2012-2022
- Basic Statistic Export value of pharmaceuticals from Sweden 2012-2022
Key players
6
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Value of chemical exports: North America 2005-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Global revenue of the chemical industry 2017-2022, by region
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Value of chemical exports: North America 2005-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Global revenue of the chemical industry 2017-2022, by region
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Hanmi Pharmaceutical. (October 23, 2024). Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2023 (in billion South Korean won)* [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. "Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2023 (in billion South Korean won)*." Chart. October 23, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. (2024). Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2023 (in billion South Korean won)*. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. "Consolidated Investment in Research and Development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2023 (in Billion South Korean Won)*." Statista, Statista Inc., 23 Oct 2024, https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical, Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2023 (in billion South Korean won)* Statista, https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/ (last visited November 21, 2024)
Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2023 (in billion South Korean won)* [Graph], Hanmi Pharmaceutical, October 23, 2024. [Online]. Available: https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/